《新股消息》巨子生物(02367.HK)今起招股 一手入場費5,595.84元
內地基於生物活性成分的專業皮膚護理產品生產商巨子生物(02367.HK)公布招股詳情,擬全球發售2,260.88萬股,香港公開發售佔近一成,國際發售佔近九成,每股招股價介乎24.3至27.7元。每手200股計,一手入場費5,595.84元。
該股今日(10月25日)起招股,周五(10月28日)中午截止,預期將於11月4日掛牌。聯席保薦人為高盛及中金。
如以招股價中位數26元計,公司上市料淨集資約5.32億元,當中約11%用於研發投資以通過招聘擴大研發團隊、擴展研發設施及進行測試和驗證研究;約28%用於擴展與產品組合及生物活性成分有關的生產能力;約46%用於增強全渠道銷售及經銷網絡,並開展以科學和知識為導向的營銷活動以提高品牌知名度;約5%用於提升營運及信息系統;約10%用於營運資金及一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.